Quantcast
Last updated on April 16, 2014 at 7:25 EDT

Latest Dopamine Stories

2013-03-04 04:21:32

NESS ZIONA, Israel, March 4, 2013 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ], Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously sub-cutaneously through a patch pump. It is designed to provide steady levodopa blood levels for the reduction of motor complications in Parkinson's...

2013-02-27 12:27:30

-- $53 million matched, positioning Foundation for continued impact; opportunity and need persist in challenged research funding environment -- NEW YORK, Feb. 27, 2013 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced that with the help of the Parkinson's community, it has completed and surpassed the $50-million Brin Wojcicki Challenge. Longtime Foundation supporters Sergey Brin and Anne Wojcicki have matched more than $53 million in...

2013-02-07 08:28:06

KALAMAZOO, Mich., Feb. 7, 2013 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today that it has received an award from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to conduct preclinical research on a first-in-class mTOT Modulator, MSDC-0160, as a potential treatment for levodopa induced dyskinesia (LID). The study will be undertaken in collaboration with Patrik Brundin, MD, PhD, of Van Andel Institute (VAI). The aim of the study, titled...

Social Isolation In Adolescence Can Lead To Addiction
2013-01-24 06:19:04

Alan McStravick for redOrbit.com - Your Universe Online Addiction is a serious disorder of the brain that is characterized by a chronic and compulsive need to take a substance, typically with an increase in dosage and frequency. Someone suffering from addiction will continue their behavior even in the face of negative consequences. The root cause of addiction is not specifically known, however. A new study out of the University of Texas at Austin (UT) may just point to one indicator of...

2013-01-23 16:24:44

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that two additional patents have been granted related to the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor (VMAT2) NBI-98854. European Patent Number 2,081,929 was granted in January 2013 by the European Patent Office with an expiration date of November 2027. This patent covers chemical compositions, pharmaceutical compositions and uses of various compounds...

Researchers Discover The Genomic Mechanism Behind Schizophrenia
2013-01-23 14:16:39

Brett Smith for redOrbit.com - Your Universe Online New research from the University of Buffalo describes the first ever genomic mechanism for schizophrenia. According to the scientists´ report in the journal Schizophrenia Research, problems with the Integrative Nuclear FGFR 1 Signaling (INFS) pathway during gestation leads to brain changes, ultimately causing behavioral problems, or schizophrenia, later in life. Previous research has shown that the pathway includes as many as 160...

2013-01-16 23:00:13

Dr. J Marshall Dent has released an article explaining that weight loss occurs in the brain. The balances of many factors play into successful weight loss and maintenance. Columbia, SC (PRWEB) January 16, 2013 Dr. J. Marshall Dent insists that, "people have been taught for years that controlling weight begins and ends with the stomach." The misconception about dieting is it´s all about creating a better ratio of “calories in versus calories out.” The truth is that weight...

Dopamine Therapy Instilling Improved Mobility, Creativeness In Parkinson’s Patients
2013-01-14 11:44:18

Lawrence LeBlond for redOrbit.com - Your Universe Online Health experts around the world are talking about a remarkable phenomenon seen in Parkinson´s patients that was first noticed by researchers at Tel Aviv University´s Sackler Faculty of Medicine over the holidays. Professor Rivka Inzelberg said patients she treated at Sheba Medical Center clinic had skipped bringing the usual presents of chocolate, flowers and knick-knacks in over the holiday season and had instead...

2013-01-09 08:27:04

SUNNYVALE, Calif., Jan. 9, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered around its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF), today presented positive preclinical efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The data...

2013-01-08 23:17:36

Penn study suggests dopamine treatments may play role in increasing impulsivity While approximately one in five Parkinson's disease patients experience impulse control disorder symptoms, the disease itself does not increase the risk of gambling, shopping, or other impulsivity symptoms, according to research from the Perelman School of Medicine at the University of Pennsylvania. A new study is the first to show in a large sample that people with untreated Parkinson's were no more likely to...